share_log

CASI Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James Huang(19.99%),Panacea Venture Healthcare Fund II, L.P.(19.31%), etc.

CASI制药 | SC 13G/A:超过5%持股股东披露文件(修正)-James Huang(19.99%),Panacea Venture Healthcare Fund II, L.P.(19.31%)等

美股SEC公告 ·  01/26 08:34
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息